From the outside, Norway can look like a haven of affluence, a country whose population of just 5.5 million is propped up by a gargantuan sovereign wealth fund worth nearly $2 trillion. Yet the ...

The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, ...

The government is not just looking at reforming the benefits system - it is preparing to put it at the heart of its economic ...